Epilepsy and Respiratory Chain Defects in Children with Mitochondrial Encephalopathies

Abstract

Objective: The purpose of this study was to determine the relationship between epilepsy and respiratory chain defects in children with mitochondrial encephalopathies (ME).

Study Design: We conducted a retrospective review of the medical records of children referred for evaluation of an ME. Only patients assigned a definite diagnosis of ME using modified Walker criteria and with a respiratory chain defect were included. Clinical data pertaining to the ME and epilepsy type were collected. Mitochondria were isolated by subcellular fractionation from a vastus lateralis muscle biopsy and studies were performed using polarographic and spectroscopic techniques for the quantitative determination of NADH and cytochrome components of the respiratory chain.

Results: A total of 38 children with ME were identified. Seizures were present in 61%. Sixteen of 23 children with epilepsy (70%) had refractory epilepsy associated with a progressive encephalopathy. Children with epilepsy had a significantly higher incidence of complex I defects than children without epilepsy (p<0.01). Complex III and IV defects were significantly higher in patients without epilepsy (p<0.01 and p<0.05, respectively) than in those with epilepsy.

Conclusions: Epilepsy is an important component of ME. The higher incidence of complex I defects in patients with epilepsy suggests a possible relationship between mitochondrial oxidative stress dysfunction and epileptogenic process.

epilepsy - EEG - mitochondrial disorders - children - muscle disease

References

• 1 Acharya MM, Katyare SS. Structural and functional alterations in mitochondrial membranes in picrotoxin-induced epileptic rat brain.  Exp Neurol. 2005;  192 79-88
• 2 Assadi M, Foley CM, Selak MA, Grover WD. Refractory epilepsy as the presenting feature in mitochondrial cytopathies.  Epilepsia. 1998;  39 ((Suppl 6)) 150
• 3 Berkovic S, Carpenter S, Evans A. et al . Myoclonus epilepsy and ragged red fibers (MERRF). A clinical, biochemical, magnetic resonance spectrographic and positron tomographic study.  Brain. 1989;  112 1231-1260
• 4 Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thornburn DA. Diagnostic criteria for respiratory chain disorders in adults and children.  Neurology. 2002;  59 1406-1411
• 5 Blumcke I, Zuschratter W, Schewe JC. et al . Cellular pathology of hilar neurons in Ammon's horn sclerosis.  J Comp Neurol. 1999;  414 437-453
• 6 Blumenthal DT, Shanske S, Schochet SS. et al . Myoclonus epilepsy with ragged red fibers and multiple mtDNA deletions.  Neurology. 1998;  50 524-525
• 7 Boyd SG. Progressive neuronal degeneration of childhood with liver disease (“Alpers disease”): Characteristic neurophysiological features.  Neuropediatrics. 1986;  17 75-80
• 8 Canofoglia L, Franchescettti S, Antozzi G. Epileptic phenotypes associated with mitochondrial disorders.  Neurology. 2001;  56 1340-1346
• 9 Chuang YC, Chang AY, Lin JW, Hsu SP, Chan SH. Mitochondrial dysfunction and ultrastructural damage in the hippocampus during kainic acid-induced status epilepticus in the rat.  Epilepsia. 2004;  45 1202-1209
• 10 Cock HR. Mitochondrial dysfunction and oxidative stress in epilepsy. In: Benjamin SM, ed. Focus on Epilepsy Research. New York: Nova Biomedical Books 2004: 105-137
• 11 Mauro S Di, Ricci E, Hirano M, Vivo DC De. Epilepsy in mitochondrial encephalomyopathy.  Epilepsy Res Suppl. 1991;  4 173-180
• 12 Mauro S Di, Kulikova R, Tanji K, Bonilla E, Hirano M. Mitochondrial genes for generalized epilepsies.  Adv Neurol. 1999;  79 411-419
• 13 Filiano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J. Mitochon-drial dysfunction in patients with hypotonia, epilepsy, autism and developmental delay: HEADD syndrome.  J Child Neurol. 2002;  17 435-439
• 14 Harden A, Pampiglione G, Battaglia A. Mitochondrial myopathy or mitochondrial disease; EEG, ERG, VEP studies in 13 children.  J Neurol Neurosurg Psychiatry. 1982;  45 627-633
• 15 Kann O, Kovacs R, Njunting M. et al . Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans.  Brain. 2005;  128 2396-2407
• 16 Kovacs R, Schuchmann S, Gabriel S. et al . Ca2+ signaling and changes of mitochondrial function during low Mg²⁺ induced epileptiform activity in organotyic hippocampal slice cultures.  Eur J Neurosci. 2001;  13 1311-1319
• 17 Kunz WS, Kudin AP, Vielhaber S. et al . Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy.  Ann Neurol. 2000;  48 766-773
• 18 Kunz WS. The role of mitochondria in epileptogenesis.  Curr Opin Neurol. 2002;  15 179-184
• 19 Kwan P, Brodie MJ. Early identification of refractory epilepsy.  N Engl J Med. 2000;  342 314-319
• 20 Lee CP, Martins ME, Tsang SH. Small scale preparation of skeletal muscle mitochondria and its application in the study of human disease in mitochondrial dysfunction. In: Lash LH, and Jones DP, eds. Methods in Toxicology, Volume II. San Diego:Academic Press 1996
• 21 Liang LP, Ho YS, Patel M. Mitochondrial superoxide production in kainate induced hippocampal damage.  Neuroscience. 2000;  101 563-570
• 22 Liang LP, Patel . Mitochondrial oxidative stress and increased sei-zure susceptibility in Sod2(-/+) mice.  Free Radic Biol Med. 2004;  36 542-544
• 23 Maertens P. Mitochondrial encephalopathy.  Semin Pediatr Neurol. 1996;  32 279-297
• 24 Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders.  Am J Med genet. 2001;  106 4-17
• 25 Nissenkorn A, Zeharia A, Lev D. et al . Neurologic presentations of mitochondrial disorders.  J Child Neurol. 2000;  15 44-48
• 26 Pavlakis SG, Phillips PC, Mauro S Di. et al . Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes: a distinctive clinical syndrome.  Ann Neurol. 1984;  16 481-488
• 27 Patel M. Mitochondria dysfunction and oxidative stress: cause and consequence of epileptic seizures.  Free Radic Biol Med. 2004;  37 1951-1962
• 28 Sarzi E, Bourdon A, Chretian D, Zarhate M, Corcos J, Slama J. et al . Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood.  J Pediatr. 2007;  150 531-534
• 29 Scaglia FS, Towbin JA, Craigen WJ. et al . Clinical spectrum, morbidity and mortality in 113 pediatric patients with mitochondrial disease.  Pediatrics. 2004;  114 925-993
• 30 Selak MA, Zhang T, Legido A. et al . Underlying biochemical defects in mitochondrial encephalopathy do not correlate with clinical or neuroradiological findings.  Ann Neurol. 1997;  42 511
• 31 Sengers RCA, Stadhouders AM, Trijbels JMF. Mitochondrial myopathies. Clinical, morphological and biochemical aspects.  Eur J Pediatr. 1984;  141 192-207
• 32 Serra G, Piccinnu R, Tondi M. et al . Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap.  Brain Dev. 1996;  18 185-191
• 33 Shah NS, Mitchell WG, Boles RG. Mitochondrial disorders: a potentially under-recognized etiology of infantile spasms.  J Child Neurol. 2002;  17 369-372
• 34 Shtilbans A, EL-Schahawi M, Malkin E, Shanske S, Musumeci O, Mauro S Di. A novel mutation in the mitochondrial DNA transfer ribonucleic acid Asp gene in a child with myoclonic epilepsy and psychomotor regression.  J Child Neurol. 1999;  14 610-613
• 35 Smith SMJ, Harding AE. EEG and evoked potential findings in mitochondrial myopathies.  J Neurol. 1993;  240 367-372
• 36 So N, Berkovic S, Andermann F, Kuzniecky R, Gendron D, Quesney FL. Myoclonus epilepsy and ragged red fibers. Electrophysiological studies and comparison with other progressive myoclonus epilepsies.  Brain. 1989;  112 1261-1276
• 37 Torbergsen T, Mathiesen E, Aasly J. Epilepsy in a mitochondrial disorder.  J Neurol Nuerosurg Psychiatry. 1991;  54 1073-1076
• 38 Tsairis P, Engel WK, Kark P. Familial myoclonic epilepsy syndrome associated with skeletal muscle mitochondrial abnormalities.  Neurology. 1973;  23 408
• 39 Tulinius M, Hagne I. EEG findings in children and adolescents with ME. A study of 25 cases.  Brain Dev. 1991;  13 167-173
• 40 Tulinius M, Holme E, Kristiansson B, Larsson N. ME in childhood. I. Biochemical and morphologic investigations.  J Pediatr. 1991;  119 242-250
• 41 Tulinius M, Holme E, Kristiansson B, Larsson N. ME in childhood II. Clinical manifestations and syndromes.  J Pediatr. 1991;  119 251-259
• 42 Uusima J, Remes AM, Rantala H. et al . Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders.  Pediatrics. 2000;  105 598-603
• 43 Zeviani M, Bertagliano B, Uziel G. Neurological presentations of mitochondrial diseases.  J Inher Metab Dis. 1990;  19 504-520

Correspondence